Chimerix Inc. (NASDAQ: CMRX) Stock Information | RedChip

Chimerix Inc. (NASDAQ: CMRX)


$3.8900
+0.0600 ( +1.57% ) 292.4K

Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.

Market Data


Open


$3.8900

Previous close


$3.8300

Volume


292.4K

Market cap


$344.60M

Day range


$3.8100 - $3.9200

52 week range


$0.7500 - $4.0700

SEC Filings


Form Type Description Pages Date
8-k 8K-related 45 May 01, 2024
def Proxies and info statements 24 Apr 26, 2024
defa14a Other 3 Apr 26, 2024
8-k 8K-related 15 Mar 21, 2024
3 Insider transactions 2 Mar 21, 2024
4 Insider transactions 1 Mar 21, 2024
upload Comment letters 2 Mar 01, 2024
10-k Annual reports 101 Feb 29, 2024
8-k 8K-related 46 Feb 29, 2024
s-3 Registration statements 13 Feb 29, 2024

Latest News


× Before browsing our site, please accept our cookies policy